论文部分内容阅读
目的:探讨香砂六君子汤加减联合三联疗法治疗Hp相关性慢性胃炎(CG)临床疗效。方法:将120例CG患者平均分为研究组与对照组。对照组应用三联疗法治疗,研究组在此基础上应用中药方剂香砂六君子汤加减治疗。结果:1研究组治疗的总有效率为95.00%,显著高于对照组的75.00%(P<0.05);2研究组Hp根除率为91.68%,显著高于对照组的70.00%(P<0.05)。结论:香砂六君子汤加减联合三联疗法治疗Hp相关性CG疗效确切,可以有效改善临床症状,提高Hp根除率,安全可靠,适于临床应用。
Objective: To investigate the clinical efficacy of Xiangsha Liujunzi Decoction combined with triple therapy in the treatment of Hp-related chronic gastritis (CG). Methods: 120 patients with CG were divided equally into study group and control group. The control group treated with triple therapy, the study group based on the application of traditional Chinese medicine prescription Xiangsha Liujunzi Decoction treatment. The total effective rate of the study group was 95.00%, significantly higher than that of the control group (75.00%, P <0.05). The Hp eradication rate was 91.68% in the study group, which was significantly higher than that in the control group (70.00%, P <0.05) ). Conclusion: Xiangsha Liujunzi Decoction combined with triple therapy is effective in treating Hp-related CG, which can effectively improve clinical symptoms, improve Hp eradication rate, be safe and reliable, and is suitable for clinical application.